A placebo-controlled, double-blind, randomized, multicenter study of ramipril 5 and 10 mg capsules and insulin infusion in subjects with unstable coronary syndromes.

Trial Profile

A placebo-controlled, double-blind, randomized, multicenter study of ramipril 5 and 10 mg capsules and insulin infusion in subjects with unstable coronary syndromes.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2011

At a glance

  • Drugs Insulin; Ramipril
  • Indications Acute coronary syndromes; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms FOCUS
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top